Isla et al. [Isla et al. 2004] studied a single nucleotide polymorphism in ERCC1 in peripheral blood lymphocytes from patients with advanced disease treated with cisplatin-based chemotherapy and concluded that patients with tumours bearing the polymorphism had a significantly better survival. This evidence concerns the gene ERCC1 and neoplasm.